Breaking News

Ocera Appoints Chief Development Officer

August 12, 2014

Patni brings leadership experience from Roche, Novartis and Pfizer

Rajiv Patni, M.D. has been appointed chief development officer at Ocera Therapeutics, Inc., effective September 2, 2014. Dr. Patni previously served as senior vice president for Actelion U.S. He also served as vice president at Roche and held leadership positions at Novartis and Pfizer.
 
"I am delighted to have Rajiv join our management team and expect that he will make significant contributions to the development of OCR-002," said Linda Grais, M.D., chief executive officer of Ocera. "Rajiv has been involved in over 15 clinical development programs, across several therapeutic areas, including acute care indications. Rajiv also served as an academic physician and trained in internal medicine and cardiology. Rajiv's experience both in the clinic and in industry will be an invaluable asset to Ocera."
 
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks